🇺🇸 Uroselective alpha-1-adrenergic receptor antagonist in United States

Uroselective alpha-1-adrenergic receptor antagonist (Uroselective alpha-1-adrenergic receptor antagonist) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Uroselective alpha-1-adrenergic receptor antagonist in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Uroselective alpha-1-adrenergic receptor antagonist approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Uroselective alpha-1-adrenergic receptor antagonist in United States?

Mayo Clinic is the originator. The local marketing authorisation holder may differ — check the official source linked above.